India’s HPV vaccine fight in classrooms
In February 2026, India launched a national HPV vaccination drive for girls 9-14. Target: 1.15 crore girls annually. By June, ∼50 lakh were vaccinated. Progress is uneven.
A report from Delhi government schools shows why. Teachers spent months in assemblies, explaining HPV and cervical cancer in simple Hindi: "ke muka cancer". They made hand-drawn charts. They walked students to dispensaries. In one school, a teacher was the first to get vaccinated to build trust.
Yet parents hesitated. Questions: Will it affect fertility? Is it safe? Some girls who brought consent forms back with signatures, still didn’t get vaccinated because parents changed their minds after hearing rumors. In one case, a girl’s mother recalled another girl who died "after injection" though it was unrelated.
Analytically, this is a trust deficit, not a supply problem. India has the vaccine. What it lacks is consistent public messaging. Cervical cancer kills 78,000 Indian women yearly. The vaccine works best before exposure. But talking about a sexually transmitted virus in schools triggers cultural discomfort.
The bottleneck is not science. It is language, rumor, and time. Teachers are doing the work of health workers with no extra pay. ASHA workers are visiting homes one by one.
The solution: sustained campaigns in local languages, involving mothers, community leaders, and doctors. One-off assemblies won’t work. Trust is built when the same person explains it 3 times. India has eliminated polio through this method. HPV can be next. But only if we vaccinate with patience, not just vials.